Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. [electronic resource] by
- Jäger, E
- Ringhoffer, M
- Dienes, H P
- Arand, M
- Karbach, J
- Jäger, D
- Ilsemann, C
- Hagedorn, M
- Oesch, F
- Knuth, A
Producer: 19960829
In:
International journal of cancer vol. 67
Availability: No items available.
|
|
15.
|
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. [electronic resource] by
- Jäger, E
- Chen, Y T
- Drijfhout, J W
- Karbach, J
- Ringhoffer, M
- Jäger, D
- Arand, M
- Wada, H
- Noguchi, Y
- Stockert, E
- Old, L J
- Knuth, A
Producer: 19980203
In:
The Journal of experimental medicine vol. 187
Availability: No items available.
|
|
16.
|
Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signalling. [electronic resource] by
- Chen, J
- Schmitt, A
- Chen, B
- Rojewski, M
- Rübeler, V
- Fei, F
- Yu, Y
- Yu, X
- Ringhoffer, M
- von Harsdorf, S
- Greiner, J
- Götzz, M
- Guillaume, P
- Döhner, H
- Bunjes, D
- Schmitt, M
Producer: 20090303
In:
Journal of cellular and molecular medicine vol. 12
Availability: No items available.
|
|
17.
|
Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome. [electronic resource] by
- Wais, V
- Kündgen, L
- Bohl, S R
- von Harsdorf, S
- Schlenk, R F
- Döhner, K
- Teleanu, V
- Bullinger, L
- Nguyen, T M
- Drognitz, K
- Moulin, J-C
- Binnenhei, M
- Bentz, M
- Döhner, H
- Bunjes, D
- Kuchenbauer, F
- Ringhoffer, M
Producer: 20190308
In:
Bone marrow transplantation vol. 53
Availability: No items available.
|
|
18.
|
Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCT. [electronic resource] by
- Bohl, S
- von Harsdorf, S
- Mulaw, M
- Hofmann, S
- Babiak, A
- Maier, C P
- Schnell, J
- Hütter-Krönke, L-M
- Scholl, K
- Wais, V
- Schlenk, R F
- Bullinger, L
- Ringhoffer, M
- Döhner, H
- Bunjes, D
- Bommer, M
- Kuchenbauer, F
Producer: 20180213
In:
Bone marrow transplantation vol. 51
Availability: No items available.
|
|
19.
|
Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma. [electronic resource] by
- Knop, S
- Langer, C
- Engelhardt, M
- Mügge, L-O
- Reichle, A
- Rösler, W
- Bassermann, F
- Hertenstein, B
- Kunitz, A
- Röllig, C
- Ostermann, H
- Schäfer-Eckart, K
- Ringhoffer, M
- Günther, A
- Junghanss, C
- Biersack, H
- Schreder, M
- Liebert, A
- Held, S
- Einsele, H
- Bargou, R C
Producer: 20180612
In:
Leukemia vol. 31
Availability: No items available.
|
|
20.
|
Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure. [electronic resource] by
- Wattad, M
- Weber, D
- Döhner, K
- Krauter, J
- Gaidzik, V I
- Paschka, P
- Heuser, M
- Thol, F
- Kindler, T
- Lübbert, M
- Salih, H R
- Kündgen, A
- Horst, H-A
- Brossart, P
- Götze, K
- Nachbaur, D
- Köhne, C-H
- Ringhoffer, M
- Wulf, G
- Held, G
- Salwender, H
- Benner, A
- Ganser, A
- Döhner, H
- Schlenk, R F
Producer: 20171017
In:
Leukemia vol. 31
Availability: No items available.
|